Making Sense of Merck's Pharmaceutical Business
Can any of Merck's new drugs fill the void left by the patent expiration of its former top-selling asthma treatment, Singulair?
Why Is Johnson & Johnson's Pharmaceutical Segment Outgrowing Its Other Businesses?
J&J’s pharmaceuticals business outgrew its other businesses in the third quarter, becoming the company’s core growth driver. What does this mean for the company’s investors?